Loading... Search for a stock... Select a stock No results found Metric vs View Metrics Details Hide Metrics Details Current Price 52-Week Range Market Cap Industry Sector Show Charts Show Table Historical Chart Simple Table Financial Charts Statement Tables Market Information Market Capitalization Valuation Metrics Price Ratios Financial Health Dividends Enterprise Value Metrics Growth Metrics Cash & Liquidity Price-to-Sales Ratio (TTM) Enterprise Value EV/Revenue Ratio Gross Profit Margin Revenue per Share (TTM) Earnings per Share (Diluted) Beta (Stock Volatility) Return on Invested Capital Debt-to-Assets Ratio Cash Ratio Inventory Turnover Asset Turnover Market Cap Category All-Time High % from 52W High % from All-Time High Quarterly Revenue Growth Quarterly Earnings Growth Book Value per Share (MRQ) Cash per Share (MRQ) Operating Cash Flow (TTM) Levered Free Cash Flow (TTM) Revenue/Sales Cost of Goods Sold Gross Profit Gross Profit Margin Research & Development % of Sales on R&D Operating Income (EBIT) EBITDA Pre-Tax Income Income Tax Net Income (Profit) Profit Margin Cash & Equivalents Total Current Assets Total Current Liabilities Current Ratio Long-Term Debt Total Shareholders Equity Retained Earnings Property, Plant & Equipment Operating Cash Flow Capital Expenditures Free Cash Flow Debt Repayment Common Stock Repurchase Last 12-Month Dividend Yield Last 12-Month Dividend Next Dividend Date Ex-Dividend Date (estimated) N/A News Sentiment News Based Sentiment Overview News based Sentiment: Key Insights: View %s News Sentiment Analysis News sentiment data is not available for %s at this time.

Home
Compare
PAR vs ^NSEI

Par Drugs [PAR] vs NIFTY 50 [^NSEI] Detailed Stock Comparison

Par Drugs

NSE

NIFTY 50

index

Index Comparison

You are comparing market indices. Financial metrics such as P/E ratios, dividend yields, and financial statements are not available for indices as they represent market benchmarks rather than individual companies.

Available data includes: price performance, historical charts, and basic market statistics.

Complete Par Drugs Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

You're looking at Par Drugs and thinking "this could be a good investment." But how do you know for sure? What if there's a similar company that's actually growing faster, has less debt, or pays better dividends? That nagging "what if" feeling is exactly why smart investors always compare before they buy.

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

Is the stock price reasonable compared to how much money the company makes? Sometimes a $200 stock is actually cheaper than a $50 stock when you look at the bigger picture.

🏥 Which Company is Healthier

Does the company make good money and have manageable debt? You want to invest in companies that can weather tough times, not ones that might struggle if business gets rough.

📈 Which Has Been Growing Faster

Look at how the stocks have performed over the past few years. One might be having a great year while the other has been consistently growing for decades.

💵 Which Pays You Better

If you want your investments to pay you while you hold them, compare how much each company gives back to shareholders through dividends.

Performance

Key Stats

Par Drugs vs NIFTY 50 Stock Performance Analysis

Loading Price Chart...

Par Drugs

NIFTY 50

Par Drugs Stock Overview | NIFTY 50 Stock Overview

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Par Drugs	-1.60%	0.11%	1.83%	10.07%	11.30%	-49.41%
NIFTY 50	0.12%	2.02%	1.35%	-1.39%	13.30%	5.75%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Par Drugs	-55.39%	-29.68%	300.15%	323.60%	323.60%	323.60%
NIFTY 50	0.58%	46.10%	113.46%	204.78%	314.15%	419.03%